• LAST PRICE
    20.3600
  • TODAY'S CHANGE (%)
    Trending Up0.2500 (1.2432%)
  • Bid / Lots
    20.0100/ 1
  • Ask / Lots
    20.7300/ 1
  • Open / Previous Close
    20.0100 / 20.1100
  • Day Range
    Low 20.0100
    High 20.3700
  • 52 Week Range
    Low 19.8800
    High 44.0900
  • Volume
    156,226
    average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 20.11
TimeVolumeFLGT
09:32 ET510020.01
09:34 ET10820.11
09:41 ET30020.16
09:43 ET50020.18
09:45 ET40020.255
09:48 ET63520.29
09:50 ET46520.33
09:52 ET50020.26
09:56 ET20020.27
10:01 ET34820.27
10:03 ET60020.26
10:08 ET10020.28
10:12 ET20020.3
10:14 ET23520.2842
10:15 ET20020.34
10:19 ET20020.3
10:21 ET30020.32
10:24 ET78420.3225
10:26 ET20020.32
10:28 ET20020.3
10:32 ET20020.33
10:33 ET70020.29
10:35 ET10020.25
10:44 ET20020.21
10:50 ET70020.22
10:57 ET10020.2205
11:00 ET10020.25
11:02 ET40020.24
11:04 ET10020.185
11:06 ET10020.18
11:09 ET16720.1739
11:15 ET71720.1742
11:18 ET120020.19
11:20 ET22520.16
11:22 ET178520.16
11:24 ET10020.16
11:29 ET50020.15
11:31 ET20020.14
11:36 ET20220.13
11:38 ET10020.13
11:40 ET40020.13
11:44 ET20020.11
11:45 ET28520.11
11:47 ET48620.09
11:51 ET91120.15
11:54 ET188820.1799
11:56 ET34120.2
11:58 ET20020.19
12:02 ET19220.18
12:03 ET29520.1811
12:05 ET39620.195
12:07 ET20020.225
12:09 ET20020.2082
12:14 ET120020.14
12:16 ET11120.1401
12:20 ET12820.1356
12:23 ET30020.11
12:25 ET10020.11
12:30 ET93920.14
12:32 ET20020.17
12:34 ET10020.186
12:36 ET10020.19
12:39 ET10020.185
12:43 ET69720.21
12:45 ET10020.23
12:52 ET10020.27
12:56 ET10020.29
12:57 ET20020.27
01:10 ET10020.2899
01:12 ET150020.25
01:15 ET30020.23
01:17 ET20020.22
01:19 ET20020.21
01:24 ET58520.19
01:26 ET30020.17
01:28 ET46120.135
01:33 ET10020.11
01:35 ET10020.1
01:39 ET32720.1
01:42 ET20020.095
01:44 ET30020.11
01:50 ET20620.13
01:51 ET10020.14
01:53 ET30020.13
01:55 ET10020.135
02:04 ET30020.11
02:06 ET65020.075
02:11 ET14120.0846
02:13 ET20020.11
02:15 ET95220.11
02:20 ET10020.13
02:24 ET20020.16
02:26 ET22520.16
02:27 ET120020.11
02:29 ET10020.11
02:31 ET50020.12
02:36 ET106820.1766
02:38 ET40020.15
02:40 ET10020.16
02:42 ET20020.145
02:44 ET20020.16
02:47 ET47620.177
02:49 ET30020.18
02:54 ET45020.18
02:56 ET45420.2
02:58 ET30020.21
03:00 ET10020.2093
03:02 ET70020.2443
03:03 ET117620.27
03:07 ET80020.255
03:09 ET80020.22
03:14 ET20020.27
03:16 ET10020.26
03:18 ET10020.27
03:20 ET79620.26
03:21 ET10020.24
03:23 ET50020.2
03:27 ET20020.22
03:30 ET50020.235
03:32 ET50020.2
03:36 ET30020.195
03:38 ET20020.21
03:41 ET44520.22
03:43 ET10020.22
03:45 ET161820.18
03:48 ET60020.205
03:50 ET10020.2
03:52 ET100020.195
03:54 ET30020.22
03:56 ET282020.25
03:57 ET434520.33
03:59 ET2703920.36
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesFLGT
Fulgent Genetics Inc
608.8M
-3.6x
---
United StatesCHTH
CNL Healthcare Properties Inc
544.1M
-21.0x
---
United StatesPNTG
Pennant Group Inc
616.9M
45.8x
-5.49%
United StatesACCD
Accolade Inc
706.7M
-5.5x
---
United StatesGMRE
Global Medical REIT Inc
537.2M
36.3x
-8.35%
United StatesTALK
Talkspace Inc
530.4M
-26.8x
---
As of 2024-04-20

Company Information

Fulgent Genetics, Inc. is a technology-based genetic company with a laboratory services business and a therapeutic development business. The Company’s laboratory services business includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform designed to improve the therapeutic window and pharmacokinetic profile (PK) profile of new and existing cancer drugs. Its technology platform for its laboratory services business includes gene probes, data suppression and comparison algorithms, learning software, and laboratory information management systems. The platform provides a test menu, the ability to rapidly develop and launch new tests and customizable test offerings. The Company also offers next-generation sequencing (NGS) services.

Contact Information

Headquarters
4399 SANTA ANITA AVEEL MONTE, CA, United States 91731
Phone
626-350-0537
Fax
626-454-1667

Executives

Chairman of the Board, Chief Executive Officer
Ming Hsieh
President, Chief Operating Officer
Jian Xie
Chief Financial Officer
Paul Kim
Chief Scientific Officer
Hanlin Gao
Independent Director
Regina Groves

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$608.8M
Revenue (TTM)
$289.2M
Shares Outstanding
29.9M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.43
EPS
$-5.64
Book Value
$38.31
P/E Ratio
-3.6x
Price/Sales (TTM)
2.1
Price/Cash Flow (TTM)
---
Operating Margin
-67.61%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.